This website uses cookies to enhance the user experience.
RADFORSK INVESTERINGSSTIFTELSE

RADFORSK INVESTERINGSSTIFTELSE952 715 704

Financial support
Foundation
Ullernchausséen 64 0379 OSLO, Norge

RADFORSK INVESTERINGSSTIFTELSE

Radforsk is an early stage Evergreen Fund dedicated to oncology, and one of the most successful pre-seed investment firms in Europe.

Links

Organization

Chairman of the board
Years since formation
30 years
since Feb 19, 1995
Type
Foundation
VAT registered
Yes
Number of employees
5

Financials

Total operating income 2024
5,374,000
NOK
Annual total result 2024
-615,650,000
NOK
Total equity 2024
81,697,000
NOK
Last update: Jul 8, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Board Member-
Chairman-
Board Member-
Board Member-

Others

NameRoleShares
K
KPMG AS
Auditor-
Last update: Mar 28, 2025

Ownership

Shares owned by the RADFORSK INVESTERINGSSTIFTELSE

NameShare classTotal number of sharesShare
S
SRB RADIOPHARMA HOLDING AS
Ordinary shares
105,864
35.29 %
B
BIOMOLEX AS
NO0010162266
168,863
20.3 %
N
NEXTERA AS
NO0010848534
791,184
19.32 %
Z
ZELLUNA IMMUNOTHERAPY AS
NO0010820731
1,834,205
14.97 %
H
HUBRO THERAPEUTICS AS
NO0012442260
245,417
5.93 %
Ordinary shares
13,533
5.83 %
Z
ZELLUNA ASA
NO0010851603
1,519,263
4.42 %
N
NYKODE THERAPEUTICS ASA
NO0010714785
10,315,311
3.16 %
A
ADJUTEC PHARMA AS
Ordinary shares
837
1.71 %
O
ONCOINVENT ASA
NO0010779341
651,110
0.71 %
L
LEDIDI AS
Ordinary shares
4,300
0.25 %
P
PCI BIOTECH HOLDING ASA
NO0010405640
70,664
0.19 %
S
SERODUS AS
NO0010549801
1
< 0.01 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
5,374,000
4,252,000
7,447,000
6,697,000
Annual Total Result
-615,650,000
-181,992,000
589,561,000
-21,912,000
Total assets
117,976,000
849,040,000
1,012,759,000
386,393,000
Total liabilities
36,279,000
151,693,000
133,421,000
96,617,000
Total equity
81,697,000
697,347,000
879,338,000
289,776,000

P&L

Year2024202320222021
Total operating income
5,374,000
4,252,000
7,447,000
6,697,000
Total operating costs
16,699,000
18,760,000
18,198,000
26,571,000
Operating result
-11,325,000
-14,508,000
-10,751,000
-19,874,000
Financial income/costs
-604,325,000
-167,484,000
600,312,000
-2,038,000
Profit before tax
-615,650,000
-181,992,000
589,561,000
-21,912,000
Total tax & extraordinary income/cost
0
0
0
0
Annual Total Result
-615,650,000
-181,992,000
589,561,000
-21,912,000

Balance overview

Year2024202320222021
Total fixed assets
139,000
139,000
139,000
139,000
Total current assets
117,837,000
848,901,000
1,012,620,000
386,254,000
Total assets
117,976,000
849,040,000
1,012,759,000
386,393,000
Short term debt
14,345,000
25,774,000
24,108,000
28,617,000
Long term debt
21,934,000
125,920,000
109,313,000
68,000,000
Total liabilities
36,279,000
151,693,000
133,421,000
96,617,000
Contributed capital
1,000,000
1,000,000
1,000,000
1,000,000
Retained earnings
80,697,000
696,347,000
878,338,000
288,776,000
Total equity
81,697,000
697,347,000
879,338,000
289,776,000
Total equity and liabilities
117,976,000
849,040,000
1,012,759,000
386,393,000

Classification

Type of organization
Foundation
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
1120
Public incorporated enterprises, owned by central government
Standard industrial classification
S
Main industrial area
Other service activities
94
Activity
Activities of membership organisations
94.9
Main industrial group
Activities of other membership organisations
94.99
Industrial group
Activities of other membership organisations n.e.c.
94.992
Industrial group
Charities which distribute means themselves